Dr. Christopher Thomas Tallman, MD

Dr. Tallman practices at Urology Medical Specialists, PA in Delray Beach, Florida.

Dr. Tallman's NPI, 1962897074, was assigned on April 6, 2015. Dr. Tallman graduated from Medical University of the Americas in 2015. Dr. Tallman holds Florida license ME149596.

Dr. Tallman's primary practice is Urology Medical Specialists, PA, at 5258 Linton Blvd, Delray Beach, FL 33484 in Palm Beach County. The practice phone is (954) 943-1133.

Dr. Tallman's primary practice is Urology Medical Specialists, PA in Delray Beach, Florida. Dr. Tallman is also affiliated with Delray Medical Center. The medical group on file is Urology Medical Specialists. Dmand AI also links Dr. Tallman to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tallman practices, 7 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Tallman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dmand AI has Dr. Tallman's licenses on file in 3 states: Florida, Texas and Michigan.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate inflammation or infection among the conditions Dr. Tallman treats.

CMS data shows 4,688 Medicare services from Dr. Tallman across 18 procedure codes in 2024, for 1,143 Medicare patients. Medicare paid $349,232 for them.

CMS counts 1,143 Medicare patients who saw Dr. Tallman in 2024. The largest group is 75 to 84, with 465 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 12% are also on Medicaid. Their average risk score is 2.10, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tallman's median patient age at 72, with 23% women.

In 2024, Dr. Tallman wrote 1,125 Medicare Part D claims for 444 patients. 77% of them were for generic drugs. CMS names the drug for 987 of them, across 16 drugs with 11 or more claims each, at $212,343 in total drug cost. In 2023, CMS named 665 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Tallman for performance year 2024, reported individually. Dr. Tallman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tallman as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Tallman, published from 2010 to 2021. 2011 was the busiest year, with 4. The most frequent topics are Urinary Bladder Neoplasms, Cystectomy and Disease Progression. Dr. Tallman has published most often in Urology. Dr. Tallman's most frequent co-authors are Firas Faik Hazem Abdollah, MD, Ahmed Abdelrahim Mohamed Aboumohamed, MD and Ajjai Shivaram Alva, MD.

Dmand AI links Dr. Tallman to 1 clinical trial. Conditions studied include Prostatic Neoplasms and Prostatic Diseases.

CMS Open Payments shows 148 general payments to Dr. Tallman from 30 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 78% of the total. Boston Scientific Corporation paid the most, $4,753.

Dr. Tallman graduated from Medical University of the Americas in 2015. Dr. Tallman is a member of ACS and AUA.

Dr. Tallman is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.